KemPharm

$0.7761
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0011 (0.14%) As of 9:32 AM EDT today
+$0.0011 (0.14%) Today

Why Robinhood?

You can buy or sell KemPharm and other stocks, options, ETFs, and crypto commission-free!

About KMPH

KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. Read More It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.

Employees
33
Headquarters
Celebration, Florida
Founded
2006
Market Cap
23.06M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
213.09K
High Today
$0.78
Low Today
$0.76
Open Price
$0.78
Volume
5.83K
52 Week High
$5.47
52 Week Low
$0.74

Collections

KMPH Earnings

-$1.77
-$1.25
-$0.73
-$0.21
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.33 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.